| Trial Status | Recruitment suspended |
| Dates | Date of activation: 27-May-11 |
| Data management at EORTC | Full |
| Phase | 2-3 |
| Randomized trial | Yes |
| Type | Advanced |
| Targeted Sample size | EORTC Groups: 250 - All Groups: 370 |
| Number of steps | 1 |
| Drug | Doxorubicin Trabectedin |
| Study Staff | Binh Bui-Nguyen (Study Coordinator) - Institut Bergonie, Bordeaux Saskia Litiere (Statistician) - EORTC Headquarters, Brussels Axelle Nzokirantevye (Data Manager) - EORTC Headquarters, Brussels Sandrine Marreaud (Coordinating Physician) - EORTC Headquarters, Brussels Anne Kirkpatrick (Project Manager) - EORTC Headquarters, Brussels, anne.kirkpatrick( at )eortc.be, +32 27741691 Gloria Montanes (Clinical Research Associate) - EORTC Headquarters, Brussels |
| Type of cancer | Soft Tissue and Bone Sarcoma |
| Participating Groups | EORTC Soft Tissue and Bone Sarcoma Group(Coordinating Group) Sarcoma Alliance for Research through Collaboration |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT01189253 |
| EudraCT | 2009-014889-26 |
| Protocol documents in PDF (requires password) | Study documentation |